Skip to main content
Mankind Pharma Limited logo

Mankind Pharma Limited — Investor Relations & Filings

Ticker · MANKIND ISIN · INE634S01028 LEI · 33580067G8AZ7S8NYA02 BSE.NS Manufacturing
Open in API
Filings indexed 397 across all filing types
Latest filing 2023-10-23 Regulatory Filings
Country IN India
Listing BSE.NS MANKIND

About Mankind Pharma Limited

https://www.mankindpharma.com/

Mankind Pharma Limited focuses on the development, manufacturing, and marketing of a broad spectrum of pharmaceutical formulations and consumer healthcare products. The company’s portfolio spans various therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, dermatology, and respiratory health. It maintains a significant presence in the over-the-counter segment with brands such as Manforce, Prega News, and Gas-O-Fast. The organization operates a robust research and development infrastructure dedicated to creating affordable and accessible medicinal solutions. Its operational model leverages an extensive distribution network to ensure product availability across diverse geographic regions, prioritizing high-quality healthcare delivery and patient-centric innovation.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about an upcoming investor conference call for the Q2FY24 period, including details on the date, time, and access information. It does not contain any financial data, analysis, or results itself, but rather serves as an announcement of the event. The document length is short (2071 characters), and it explicitly states the call will be held on a future date. Therefore, it is not a transcript or report but an announcement of the call. According to the filing definitions, this fits best under Call Transcript (CT) only if it were the transcript itself, but since this is an invitation/notice, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement about the call and does not fit other categories. The confidence is high due to clear content and format.
2023-10-23 English
Updates
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to stock exchanges regarding a change in senior management personnel. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including management changes. The content details the appointment of a new President – Global Chief Human Resource Officer, including the date of appointment and a brief profile. There are no financial statements, earnings data, or report attachments. The document is clearly an announcement of a management change rather than a full report or other filing type. Therefore, it fits the category of Board/Management Information (MANG). The document length is 3153 characters, which is consistent with a concise announcement rather than a full report.
2023-10-16 English
Updates
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges regarding the resumption of operations at a manufacturing facility after a disruption caused by flash floods. It references compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document includes details about the event, impact, and restoration steps but does not contain financial statements or detailed financial analysis. The length is 2818 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. There is no indication that this is an annual report, earnings release, or other detailed financial document. Therefore, this is best classified as a Regulatory Filing (RNS) as it is a general regulatory announcement about a material event affecting operations.
2023-10-13 English
Board Meeting — MANKIND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 31-Oct-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for th…
Regulatory Filings
2023-10-11 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges about an upcoming Board Meeting scheduled for October 31, 2023. The purpose of the meeting is to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2023. It also mentions the closure of the trading window due to insider trading regulations. The document is short (1681 characters) and serves as an announcement of a future event rather than containing any financial data or results itself. It does not contain actual financial statements or detailed analysis, so it is not an Interim/Quarterly Report (IR) or Earnings Release (ER). It is also not a full Annual Report or Audit Report. The document is a regulatory announcement informing about the Board Meeting and related compliance matters, which fits best under Regulatory Filings (RNS).
2023-10-11 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming no requests for dematerialization/rematerialization of shares for the quarter ended September 30, 2023. It is a compliance certificate from the Registrar and Share Transfer Agent addressed to the company secretary. The document length is short (2049 characters) and it primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or any report publication. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and miscellaneous regulatory documents that do not fit other specific categories.
2023-10-10 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.